Kromek Group (LSE:KMK) said it expects full-year 2026 revenue and profit before tax to meet market expectations, supported by stronger demand across its CBRN Detection and Advanced Imaging businesses.
The company reported increased sales within its chemical, biological, radiological and nuclear (CBRN) Detection division alongside continued underlying growth in Advanced Imaging operations. Performance during the second half was further supported by £8.8 million in new orders, reinforcing demand for Kromek’s specialist detection technologies in critical security and healthcare applications.
Within the Advanced Imaging segment, Kromek said it secured several long-term contracts and successfully managed supply chain challenges through a major follow-on order from an existing customer. Excluding the impact of a prior exceptional agreement with Siemens Healthineers, the division continued to demonstrate solid operational progress.
The CBRN Detection business also delivered year-on-year revenue growth despite some delays affecting government procurement programmes. Management said momentum across both divisions remains encouraging as the company continues to focus on executing its strategic growth priorities.
Kromek’s outlook is supported by improving financial performance, including stronger revenue growth, expanding margins and relatively low leverage. Free cash flow trends remain somewhat mixed, while technical indicators continue to point to positive momentum and an established upward trend. However, elevated RSI and stochastic readings suggest the shares may face some near-term pullback risk. Valuation remains moderate, with the stock trading on a price-to-earnings ratio of around 20.5 and offering no dividend yield.
More about Kromek Group plc
Kromek Group plc is a UK-based technology company specialising in radiation detection and bio-detection systems for medical imaging, security and industrial applications. The group develops CZT-based detector technology used in CT and SPECT imaging systems, while also supplying compact radiation detectors and biosecurity solutions for homeland security, defence and critical infrastructure protection markets.
Leave a Reply